BSE Live
Oct 01, 16:01Prev. Close
35.86
Open Price
35.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
Profit & Loss account of Shukra Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
INCOME | ||||||
Revenue From Operations [Gross] | 32.59 | 68.57 | 48.80 | 12.90 | 7.89 | |
Less: Excise/Sevice Tax/Other Levies | 0.00 | 0.00 | 0.00 | 0.00 | 2.92 | |
Revenue From Operations [Net] | 32.59 | 68.57 | 48.80 | 12.90 | 4.98 | |
Total Operating Revenues | 32.59 | 74.57 | 58.83 | 20.49 | 11.20 | |
Other Income | 4.21 | 2.82 | 1.20 | 0.08 | 0.36 | |
Total Revenue | 36.79 | 77.39 | 60.03 | 20.57 | 11.55 | |
EXPENSES | ||||||
Cost Of Materials Consumed | 11.75 | 13.38 | 11.35 | 11.08 | 2.96 | |
Purchase Of Stock-In Trade | 0.00 | 30.41 | 34.30 | 0.00 | 0.00 | |
Operating And Direct Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Changes In Inventories Of FG,WIP And Stock-In Trade | -3.63 | 0.70 | -0.33 | -0.73 | -0.19 | |
Employee Benefit Expenses | 6.11 | 5.65 | 4.89 | 4.90 | 4.07 | |
Finance Costs | 0.59 | 0.29 | 0.28 | 0.29 | 0.03 | |
Depreciation And Amortisation Expenses | 3.00 | 2.05 | 1.84 | 1.66 | 1.47 | |
Other Expenses | 5.64 | 5.04 | 3.26 | 2.35 | 2.92 | |
Total Expenses | 23.46 | 57.50 | 55.59 | 19.55 | 11.26 | |
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax | 13.34 | 19.88 | 4.44 | 1.02 | 0.29 | |
Exceptional Items | 0.00 | 0.00 | 0.00 | 0.00 | -0.20 | |
Profit/Loss Before Tax | 13.34 | 19.88 | 4.44 | 1.02 | 0.10 | |
Tax Expenses-Continued Operations | ||||||
Current Tax | 3.76 | 1.36 | 0.00 | 0.18 | 0.05 | |
Less: MAT Credit Entitlement | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Deferred Tax | 0.00 | -0.02 | 0.03 | 0.06 | 0.02 | |
Tax For Earlier Years | 0.00 | 0.00 | 0.01 | 0.04 | 0.00 | |
Total Tax Expenses | 3.76 | 1.35 | 0.04 | 0.27 | 0.06 | |
Profit/Loss After Tax And Before ExtraOrdinary Items | 9.58 | 18.54 | 4.41 | 0.75 | 0.03 | |
Profit/Loss From Continuing Operations | 9.58 | 18.54 | 4.41 | 0.75 | 0.03 | |
Profit/Loss For The Period | 9.58 | 18.54 | 4.41 | 0.75 | 0.03 | |
OTHER ADDITIONAL INFORMATION | ||||||
EARNINGS PER SHARE | ||||||
Basic EPS (Rs.) | 0.22 | 16.93 | 26.21 | 4.79 | 0.22 | |
Diluted EPS (Rs.) | 0.22 | 16.93 | 26.21 | 4.79 | 0.22 | |
VALUE OF IMPORTED AND INDIGENIOUS RAW MATERIALS STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
STORES, SPARES AND LOOSE TOOLS | ||||||
Imported Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Indigenous Stores And Spares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
DIVIDEND AND DIVIDEND PERCENTAGE | ||||||
Equity Share Dividend | 0.00 | 0.07 | 0.08 | 0.00 | 0.00 | |
Tax On Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Equity Dividend Rate (%) | 1.00 | 10.00 | 5.00 | 5.00 | 0.00 |
12.06.2025
Shukra Pharma Standalone March 2025 Net Sales at Rs 13.27 crore, up 21.92% Y-o-Y
26.11.2024
Shukra Pharma Standalone September 2024 Net Sales at Rs 5.56 crore, down 77.45% Y-o-Y
13.08.2024
Shukra Pharma Standalone June 2024 Net Sales at Rs 3.18 crore, down 84.24% Y-o-Y
07.06.2024
Shukra Pharma Standalone March 2024 Net Sales at Rs 10.88 crore, down 76.47% Y-o-Y